Project Pink Campaign
Breast cancer is the second leading cause of cancer related deaths in Australian women, with over 3,000 losing their life each year. You can help reduce these numbers by fundraising or making a donation to one of the 130 Australian Leisure and Hospitality Group (ALH) venues who are raising funds for breast cancer research.
Project Pink isn’t just about raising funds for innovative research, but also encourages women to be proactive with their health, early detection is key to a more positive prognosis.
Purpose
The Project Pink Campaign is an innovative public awareness campaign designed to bring attention to the fight against breast cancer and to support cancer research organizations in combating this devastating disease.
About them
Project Pink is the PA Research Foundation's breast cancer campaign that runs annually with partners Australian Leisure and Hospitality Group (ALH), Aveo Group, Stellarossa Coffee Stores and Network 10.
They are funded by their partners, donations and by raising interactive programs that you can participate. Examples of these programs are: Smiddy Fun Week, Play for Purpose, and Containers for a change.
How the Funds Help
Triple Negative Breast Cancer
Dr Katherine Cuff and Dr Adrian Wiegmans are conducting a liquid biomarker study on triple negative breast cancer, a particularly aggressive sub-type of breast cancer that tends to occur in younger women.
Currently women with triple negative breast cancer can only be treated with surgery and chemotherapy and sadly treatment is unsuccessful for some patients. This new liquid biomarker study aims to uncover why those patients didn't respond to treatment, which could be a game changer for women with this type of breast cancer.
HER2 Positive Breast Cancer
The University of Queensland Diamantina Institute Simpson Lab team are working alongside Professor Walpole and Professor Lim on a safety trial for another aggressive type of breast cancer called HER2 positive which spreads faster than other breast cancers and can recur after treatment.
The team are working towards a large breast cancer trial in collaboration with the Kinghorn Cancer Centre and Garvan institute in Sydney involving 468 patients.
Their ultimate goal is to provide better treatment options for patients which actually stops the cancer from coming back after therapy.
Comments
Post a Comment